Evaluation of the Safety, Tolerability and Efficacy of Ezetimibe on a Select Population of Filipinos With Hypercholesterolemia (Study P04748)(COMPLETED)

NCT00704535 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4105

Last updated 2022-02-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the overall safety, tolerability, and efficacy of Ezetimibe when used alone or in combination with a statin in patients with hypercholesterolemia

Conditions

  • Primary Hypercholesterolemia
  • Homozygous Familial Hypercholesterolemia

Interventions

DRUG

Ezetimibe

1 tablet of 10 mg once daily

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2008-04-30
Completion
2008-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00704535 on ClinicalTrials.gov